Apart from reclassifying IDH-wildtype astrocytomas, panel sequencing contributed to clarifying the difficult differential diagnosis between reactive gliosis and glioma infiltration in biopsy samples of limited glial cell density and confined p53 immunoreactivity. Here, IDH2 is linked to astrocytoma (excluding glioblastoma).